Your position:m.limatoxi.com>>EN>>EN>>Formulation>>Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma>> article
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
Editor:xuezhe Clicks:0Date:2023-3-31 15:49:12
Keyword:Received orphan drug
Healthoo Information:
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • THE BULK DRUG PARKS SCHEME
  • 2022 global new drug inventory: "First-in-class" therapy accounted for...
  • Domestic anti-HIV new drug, Addison Pharmaceuticals "Inomitine Tablets...
  • Inventory in 2022: Overview of "Five Xiaoqiang" Export of Veterinary D...
  • The battle between Pfizer Gilead over COVID-19 drugs will continue
  • When is "water inverse" going on? Biogens ALS drug approval delayed to...
  • Market Report of Monoclonal Antibody Drugs in China (2022)
  • The Veterinary Drug Industry is Facing a Period of Opportunity for Cha...
  • Innovative drugs - Medium long-term growth still has more room for imp...
  • Chinas innovative drugs entering the global market is the future trend...
    		•
    Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map